ArticleJornal brasileiro de nefrologia

Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study.

Marina Rezende de Fázio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.